FLG and Alzheimer disease: To investigate whether the levels of filaggrin degradation products were influenced, in addition to FLG genotype, by the presence of disease per se, we compared these levels between CTRL and FLG wild-type patients with AD (ADNON-FLG; FLG+/+).